Plasma Clearance of ⁵⁷Cobalt-Labelled Vitamin B₁₂ Bound in Vitro and in Vivo to Transcobalamin I and II

References

• Bailey J. L. Techniques in Protein Chemistry. 2nd ed. Elsevier, Amsterdam 1967; 346
   Google Scholar
• Bauer G. C. H., Carlsson A., Lindquist B. Metabolism and homeostatic function of bone. Mineral Metabolism, C. L. Comar, F. Bonner. Academic Press, New York 1961; Vol. 1: 633, part B
   Google Scholar
• Burstein M., Samaille V. Sur une nouvelle méthode de dosage du cholesterol lié aux α- et β-lipoproteines du serum. Clin. chim. Acta 1958; 3: 320
   PubMed Web of Science ®Google Scholar
• Donato L., Matthews C. M. E., Nosslin B., Segre G., Vitek F. Round table on 'Application of tracer theory to protein turnover studies. J. Nucl. biol. Med. 1966; 10: 18
   Google Scholar
• Finkler A. E., Hall C. A. Nature of the relationship between vitamin B12 binding and cell uptake. Arch. biochem. Biophys. 1967; 120: 79
   PubMed Web of Science ®Google Scholar
• Flodin P. Dextran Gels and Their Applications in Gel Filtration. Thesis, UppsalaSweden 1962
   Google Scholar
• Gabuzda T. G., Worm-Petersen I., Lous P. The binding of vitamin B12 added in vitro and in vivo to normal human serum proteins separated on ion exchange cellulose. Scand. J. Haemat. 1965; 2: 61
   PubMedGoogle Scholar
• Gräsbeck R. Intrinsic factor and the trans-cobalamins with reflections on the general function and evolution of soluble transport proteins. Scand. J. clin. Lab. Invest. 1967; 19: 7, Suppl. 95
   Web of Science ®Google Scholar
• Hall C. A. The plasma disappearance of intravenously administrated cobalt58 vitamin B12. J. clin. Invest. 1960; 39: 1312
   PubMed Web of Science ®Google Scholar
• Hall C. A. Long-term excretion of Co57-vita-min B12 and turnover within the plasma. Amer. J. clin. Nutr. 1964; 14: 156
   PubMed Web of Science ®Google Scholar
• Hall C. A., Finkler A. E. Abnormal transport of vitamin B12 in plasma in chronic myelogenous leukemia. Nature (Lond.) 1964; 204: 1207
   PubMed Web of Science ®Google Scholar
• Hall C. A., Finkler A. E. The dynamics of transcobalamin II. A vitamin B12 binding substance in plasma. J. Lab. clin. Med. 1965; 65: 459
   PubMed Web of Science ®Google Scholar
• Hall C. A., Finkler A. E. Function of transcobalamin II. A B12 binding protein in human plasma. Proc. Soc. exp. Biol. (N. Y.) 1956; 123: 55
   Google Scholar
• Horn B. Turnover studies with 57cobalt-labelled vitamin B12 binding proteins. Scand. J. clin. Lab. Invest. 1967; 19: 36, Suppl. 95 (Abstract)
   Web of Science ®Google Scholar
• Horn B. L. Plasma clearance of ⁵⁷cobalt-labelled vitamin B₁₂ bound in vitro and in vivo to transcobalamin I and II in Physiology and Pathophysiology of Plasma Protein Metabolism. Pergamon Press, London, 4, In press
   Google Scholar
• Horn B. L. Plasma turnover of 57cobalt-vita-min B12 bound to transcobalamin I and II. Scand. J. Haemat. 1967; 4: 321
   PubMedGoogle Scholar
• Horn B. L., Ahluwalia B. K. The vitamin B12 binding capacity of transcobalamin I and II of normal human serum. Scand. J. Haemat. 1968; 5: 64
   PubMedGoogle Scholar
• Horn B., Olesen H., Lous P. Fractionation of vitamin B12 binders in human serum. J. Lab. clin. Med. 1966; 68: 958
   PubMed Web of Science ®Google Scholar
• Horn B., Olesen H. Molecular weights of vitamin B12 binding proteins in human serum determined by Sephadex G-200 gel filtration. Scand. J. clin. Lab. Invest. 1967; 19: 269
   PubMed Web of Science ®Google Scholar
• Jarnum S. The amount of circulating albumin in normal humans. Scand. J. clin. Lab. Invest. 1959; 11: 269
   PubMed Web of Science ®Google Scholar
• Lindstrand K., Ståhlberg K.-G., Ehrensvärd G., Nordén A. Studies on free and serum protein-bound vitamin B12 by use of Sephadex G-25 and high voltage electrophoresis. Acta med. scand. 1963; 173: 605
   PubMedGoogle Scholar
• Mendelsohn R. S., Watkin D. M., Horbett A. P., Fahey J. L. Identification of the vitamin B12-binding protein in the serum of normals and of patients with chronic myelocytic leukemia. Blood 1958; 13: 740
   PubMed Web of Science ®Google Scholar
• Miller A., Sullivan J. F. The invitro binding of cobalt60 labelled vitamin B12 by normal and leukemic sera. J. clin. Invest. 1958; 37: 556
   PubMed Web of Science ®Google Scholar
• Monti A., Glynn M. F., Dern R. J. Studies with doubly labelled iron. III. An evaluation of ferrokinetic data obtained with various chemical forms of tracer iron. J. Lab. clin. Med. 1963; 61: 272
   Web of Science ®Google Scholar
• Olesen H., Unpublished results
   Google Scholar
• Ostrowski W., Skarzynski B., Zak Z. Vitamin B12 in the protein fractions of human blood serum. Bull. Acad. Pol. Sci. Cl. II, 1954; 2: 9
   Google Scholar
• Pitney W. R., Beard M. F., van Loon E. J. Observations on the bound form of vitamin B12 in human serum. J. biol. Chem. 1954; 207: 143
   PubMed Web of Science ®Google Scholar
• Reizenstein P., Cronkite E. P., Cohn S. A Plasma clearance and whole body turnover of injected and absorbed radioactive vitamin B12 in man. J. Lab. clin. Med. 1963; 62: 255
   PubMed Web of Science ®Google Scholar
• Reizenstein P., Ek G., Matthews C. M. E. Vitamin B12 kinetics in man. Implications on total-body-B12-determinations, human requirements, and normal and pathological cellular B12 uptake. Phys. in Med. Biol. 1966; 11: 295
   PubMed Web of Science ®Google Scholar
• Retief F. P., Gottlieb C. W., Herbert V. Delivery of Co57B12 to erythrocytes from α and β globulin of normal, B12-deficient, and chronic myeloid leukemia serum. Blood 1967; 29: 837
   Web of Science ®Google Scholar
• Weinstein I. B., Watkin D. M. Co58B12 absorption, plasma transport and excretion in patients with myeloproliferative disorders, solid tumors and non-neoplastic diseases. J. clin. Invest. 1960; 39: 1667
   PubMed Web of Science ®Google Scholar